Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral: Vanier Canada Graduate Scholarships

McGill University

$150,000.00

Elucidating disease-relevant immune cell subsets in pediatric-onset multiple sclerosis: A unique window into early disease mechanisms

FY 2014-15

Summary
Multiple Sclerosis (MS) is an inflammatory disease of the central nervous system (CNS), in which immune cells damage the covering of nerve cells in the brain and spinal cord, often leading to both physical and mental disability. Although available therapies in some cases treat the symptoms and may partially decrease new injury, such treatments are not specific and can lead to adverse effects. It is of outmost importance to investigate specific targets of the MS attack since identifying these could guide the development of more selective and safer treatments. Thus far adult MS patients have been the focus of research and clinical trials but these patients likely had MS develop many years prior. This poses a challenge in distinguishing between immune abnormalities that actually contribute to the CNS injury, from those that may develop merely as a consequence of the disease. For this reason, we are shifting our attention to pediatric-onset MS because it offers what we believe to be a "sneak peek" into the earliest biological events of this disease. This could give clues of early disease targets and the cells that cause the damage because we can examine children who present with the earliest episodes of MS. Through our methods of detection and identification at the Montreal Neurological Institute, I will characterize the disease targets and injury mechanisms in this young population, providing unique and exciting insights into the abnormalities for which we would like to develop better treatments. My proposed studies of MS in the pediatric age group could provide novel insights into the specific immune targets and the cell types involved in MS, helping early detection of the disease and ultimately leading to the development of more selective treatments. The results of such work could benefit not only the young population which presents with the first attack but through early detection of the disease, we could potentially prevent disease progression in adults.
Program
Doctoral: Vanier Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
318316
Name
Mexhitaj Ina
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Elucidating disease-relevant immune cell subsets in pediatric-onset multiple sclerosis: A unique window into early disease mechanisms
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Ads-Mono; Ads-Ms; Antigen-Specific Therapies; Cns Injury; Demyelination; Multiple Sclerosis; Pediatric Cohort; T Lymphocytes
Abstract
Multiple Sclerosis (MS) is an inflammatory disease of the central nervous system (CNS), in which immune cells damage the covering of nerve cells in the brain and spinal cord, often leading to both physical and mental disability. Although available therapies in some cases treat the symptoms and may partially decrease new injury, such treatments are not specific and can lead to adverse effects. It is of outmost importance to investigate specific targets of the MS attack since identifying these could guide the development of more selective and safer treatments. Thus far adult MS patients have been the focus of research and clinical trials but these patients likely had MS develop many years prior. This poses a challenge in distinguishing between immune abnormalities that actually contribute to the CNS injury, from those that may develop merely as a consequence of the disease. For this reason, we are shifting our attention to pediatric-onset MS because it offers what we believe to be a "sneak peek" into the earliest biological events of this disease. This could give clues of early disease targets and the cells that cause the damage because we can examine children who present with the earliest episodes of MS. Through our methods of detection and identification at the Montreal Neurological Institute, I will characterize the disease targets and injury mechanisms in this young population, providing unique and exciting insights into the abnormalities for which we would like to develop better treatments. My proposed studies of MS in the pediatric age group could provide novel insights into the specific immune targets and the cell types involved in MS, helping early detection of the disease and ultimately leading to the development of more selective treatments. The results of such work could benefit not only the young population which presents with the first attack but through early detection of the disease, we could potentially prevent disease progression in adults.
Competitiondate
201411
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Mexhitaj, Ina
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~
McGill University - $150,000 Grant (2014-15) | Canada Spends